Complete the ACER-001 bioequivalence fed trial
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 15 Jan 2021
- Due
- 31 Mar 2021
- Delivered
- February 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“ACER-001 BE fed trial completion: Q1 2021”
What we found
Evidence strength A What the grades mean
The company announced topline results from the ACER-001 bioequivalence fed trial in February 2021, confirming completion within the Q1 2021 deadline.
-
A Acer Therapeutics Inc. 8-K filed 2021-04-02
“BE trial under fed conditions completed in Q1 2021” ✓ confirmed on the page
-
A Acer Therapeutics Inc. 10-K filed 2022-03-02
“In February 2021, we announced topline results from our single-center, single-blind, randomized, single-dose crossover trial that evaluated BE of ACER-001 compared to BUPHENYL® when administered under fed conditions” ✓ confirmed on the page
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Complete
- Deliverable
- ACER-001 bioequivalence fed trial
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: Subject to additional capital
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Acer Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C069308-022130 · Corrections policy